Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Upcoming event

September 30, 2021

Erik Penser Bank Orphan Drugs

Latest presentation

Latest Report

August 19, 2021

Interim report Q2 2021

Calendar and upcoming reports

September 30, 2021

Erik Penser Bank - Orphan drugs

November 4, 2021

Interim report July-September

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com